Industry
Biotechnology
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
October 30, 2024 | 10:16 am
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 3:16 pm
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 3:11 pm
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 3:00 pm
Portfolio Pulse from Benzinga Newsdesk
October 29, 2024 | 6:06 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.